Biomarkers To Get Individual Guidances Under FDA Plan To Promote Development
Executive Summary
As part of a strategy to encourage biomarker qualification, FDA is prepared to issue guidances on the use of specific biomarkers
You may also be interested in...
Personalized Medicine Is Closer Than You Think, FDA’s Throckmorton Says
Personalized medicine should be adopted as a prospective strategy in drug development rather than primarily serving as a tool to salvage failing drug candidates, participants at FDA's Science Forum suggested
Personalized Medicine Is Closer Than You Think, FDA’s Throckmorton Says
Personalized medicine should be adopted as a prospective strategy in drug development rather than primarily serving as a tool to salvage failing drug candidates, participants at FDA's Science Forum suggested
Cancer Biomarker Prospects May Be Unrealistic, At Least For Now
The high hopes for genomics and proteomics research to yield valid cancer biomarkers may exceed the field's current capabilities, David Ransohoff (University of North Carolina) cautioned at the Institute of Medicine's National Cancer Policy Forum